New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors may protect the kidneys better than glucagon-like peptide 1 receptor ...

The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...

The use of SGLT2 inhibitors was associated with a significantly reduced risk for dementia and PD in patients with type 2 diabetes.

Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...

A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

Sodium glucose cotransporter 2 inhibitors used to treat diabetes may also reduce the risk of recurrent kidney stones and gout ...

The connection between CVD and diabetes cannot be understated, as diabetes impacts CV health and heart conditions affect ...

A collaboration of researchers led by Emory University Rollins School of Public Health, Atlanta, is urging caution when ...

There are other diabetes medications such as metformin and SGLT2 inhibitors that also aid in weight loss, Dr. Das points out.

Off-label SGLT2 inhibitors increase the risk of euglycemic diabetic ketoacidosis. GLP-1RAs may lead to rapid weight loss in ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with ...